TMO Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Elects New Director to Board

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected Dion Weisler to its board of directors, effective today. Mr. Weisler’s appointment brings the total number of Thermo Fisher board members to 12.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170301005757/en/

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it h ...

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has elected Dion Weisler to its board of directors, effective March 1, 2017. (Photo: Business Wire)

Mr. Weisler has been president and chief executive officer of HP Inc. since November 2015, following the separation of Hewlett-Packard into two independent companies. He also serves on the HP board of directors. Prior to that, Mr. Weisler was executive vice president of Hewlett-Packard’s Printing and Personal Systems Business for four years.

During his more than 25 years of experience in the information technology industry, Mr. Weisler has led businesses in at least eight international markets. Before joining HP, he was with Lenovo as vice president and chief operating officer of its Product and Mobile Internet Digital Home groups, and led the company’s Global Transaction Model worldwide. Previously, Mr. Weisler served as general manager of Lenovo’s operations in Korea, Southeast Asia, Australia and New Zealand. Earlier in his career, he was general manager at Telstra Corporation, Australia’s leading telecommunications company, and also had an 11-year career at Acer Inc., where he became managing director of the company’s operations in the United Kingdom after establishing and leading the company’s businesses in Central and Eastern Europe. He holds a Bachelor’s Degree in Applied Science - Computing from Monash University in Australia.

“We are delighted to welcome Dion to our board,” said Jim Manzi, chairman of the board of Thermo Fisher Scientific. “He brings many years of experience in international business and digital technology strategies. Given his background and global perspective, Dion will add valuable insights as we focus more and more on leveraging new digital capabilities to create a differentiated experience for our customers.”

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $18 billion and more than 55,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit www.thermofisher.com.

EN
01/03/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Thermo Fisher Scientific Inc.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Back to Near-Term Bullish on SPX and QQQ We downgraded our near-term outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ) to neutral last week (11/19/25 Compass), after being bullish since our 4/22/25 Compass, while maintaining our intermediate-term bullish outlook (as of our 5/14/25 Compass). Crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ held last week, and we are right back to being near-term bullish as long as these support levels continue to hold. Just know that SPX could see...

Thermo Fisher Scientific Inc: 2 directors

Two Directors at Thermo Fisher Scientific Inc sold after exercising options/sold 5,696 shares at between 588.265USD and 594.420USD. The significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary tra...

Moody's Ratings says Thermo Fisher's Clario acquisition expands clinic...

Moody's Ratings commented that Thermo Fisher Scientific Inc.'s (A3 positive) announcement that it entered into a definitive agreement to acquire privately held Clario Holdings, Inc. for $8.88 billion plus certain potential future payouts will add scale and earnings diversity and bolster capabilities...

Thermo Fisher Scientific Inc.: Clario acquisition expands clinical tri...

The acquisition is earnings accretive and enhances the value of services provided to research customers, while increasing leverage by about one-half turn.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch